337 results
8-K
TCRT
Alaunos Therapeutics, Inc.
21 Jun 24
Changes in Registrant's Certifying Accountant
5:01pm
firm. The decision to dismiss RSM was approved by the Company’s Audit Committee. As described below, the change in independent registered public … December 31, 2023 and 2022, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope
8-K
TCRT
Alaunos Therapeutics, Inc.
12 Jun 24
Material Modifications to Rights of Security Holders
5:01pm
office until the Company’s 2025 Annual Meeting of Stockholders (“Proposal 1”); (2) to ratify the selection by the Audit Committee of the Board of RSM …
Dale Curtis Hogue, Jr.
Robert J. Hofmeister
Robert W. Postma
Jaime Vieser
Holger Weis
Proposal 2 - Ratification of the Selection by the Audit
DEFA14A
TCRT
Alaunos Therapeutics, Inc.
26 Apr 24
Additional proxy soliciting materials
4:49pm
year ending December 31, 2024 by the audit committee (the “audit committee”) of the board of directors of the Company (the “Board”).
For
To approve
8-K
d5qzuh0q8q8lgmpas
12 Jun 23
Material Modifications to Rights of Security Holders
4:15pm
DEFA14A
6nsf3uhws3j
25 Apr 23
Additional proxy soliciting materials
5:06pm
8-K
xjrf7y
30 Mar 23
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
7:41am
8-K
EX-1.1
t5624sax
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm